Table 4.
Age (no. of events in men + women) | Site | Men HR (95% CI) | Women HR (95% CI) |
---|---|---|---|
All (70 + 88) | All | 0·91 (0·49–1·70) | 1·06 (0·64–1·74) |
⩽50 (5 + 32) | All | 0·80 (0·08–8·08) | 1·17 (0·52–2·63) |
51–65 (30 + 28) | All | 1·01 (0·41–2·46) | 0·85 (0·33–2·18) |
>65 (35 + 28) | All | 0·68 (0·35–2·11) | 1·18 (0·49–2·87) |
>65 (11 + 0) | Lung | 0·84 (0·18–3·97) | † |
>65 (9 + 0) | Prostate | ‡ | † |
>65 (0 + 8) | Breast | † | 1·18 (0·24–5·82) |
>65 (1 + 7) | Colorectal | † | 1·42 (0·24–8·54) |
>65 (6 + 7) | Haematological | 2·06 (0·37–11·56) | 1·48 (0·29–7·44) |
HR, Hazard ratio; CI, confidence interval.
No cases of malignancy were recorded in at least one of the comparison groups.
Only one case of malignancy was recorded in at least one of the comparison groups.